TP53 and hepatocellular carcinoma: To examine the therapeutic effect, five-month-old adult Tg(fabp10a:HBx,src,p53−)-DIO zebrafish with HCC were orally fed 419S1 and 420S1 at concentrations of 15 μg/g and 30 μg/g, respectively.